The University of Southampton
University of Southampton Institutional Repository

A minimum core outcome dataset for the reporting of preclinical chemotherapeutic drug studies: Lessons learned from multiple discordant methodologies in the setting of colorectal cancer

A minimum core outcome dataset for the reporting of preclinical chemotherapeutic drug studies: Lessons learned from multiple discordant methodologies in the setting of colorectal cancer
A minimum core outcome dataset for the reporting of preclinical chemotherapeutic drug studies: Lessons learned from multiple discordant methodologies in the setting of colorectal cancer
In vivo studies in animal models are critical tools necessary to study the fundamental complexity of carcinogenesis. A constant strive to improve animal models in cancer exists, especially those investigating the use of chemotherapeutic effectiveness. In the present systematic review, colorectal cancer (CRC) is used as an example to highlight and critically evaluate the range of reporting strategies used when investigating chemotherapeutic agents in the preclinical setting. A systematic review examining the methodology and reporting of preclinical chemotherapeutic drug studies using CRC murine models was conducted. A total of 45 studies were included in this systematic review. The literature was found to be highly heterogeneous with various cell lines, animal strains, animal ages and chemotherapeutic compounds/regimens tested, proving difficult to compare outcomes between similar studies or indeed gain any significant insight into which chemotherapeutic regimen caused adverse events. From this analysis we propose a minimum core outcome dataset that could be regarded as a standardised way of reporting results from in vivo experimentation.
1040-8428
80-102
West, M.A.
98b67e58-9875-4133-b236-8a10a0a12c04
Roman, A.
cc7d1a8e-5f84-4768-be04-626ded24f538
Sayan, E.
d1dbbcad-9c53-47c1-8b7e-1b45cc56e077
Primrose, J.N.
d85f3b28-24c6-475f-955b-ec457a3f9185
Wedge, S.R.
8ea95b32-9103-4656-8e2d-ecbdf9d389ee
Underwood, T.J.
8e81bf60-edd2-4b0e-8324-3068c95ea1c6
Mirnezami, A.H.
b3c7aee7-46a4-404c-bfe3-f72388e0bc94
West, M.A.
98b67e58-9875-4133-b236-8a10a0a12c04
Roman, A.
cc7d1a8e-5f84-4768-be04-626ded24f538
Sayan, E.
d1dbbcad-9c53-47c1-8b7e-1b45cc56e077
Primrose, J.N.
d85f3b28-24c6-475f-955b-ec457a3f9185
Wedge, S.R.
8ea95b32-9103-4656-8e2d-ecbdf9d389ee
Underwood, T.J.
8e81bf60-edd2-4b0e-8324-3068c95ea1c6
Mirnezami, A.H.
b3c7aee7-46a4-404c-bfe3-f72388e0bc94

West, M.A., Roman, A., Sayan, E., Primrose, J.N., Wedge, S.R., Underwood, T.J. and Mirnezami, A.H. (2017) A minimum core outcome dataset for the reporting of preclinical chemotherapeutic drug studies: Lessons learned from multiple discordant methodologies in the setting of colorectal cancer. Critical Reviews in Oncology/Hematology, 112, 80-102. (doi:10.1016/j.critrevonc.2017.02.008).

Record type: Article

Abstract

In vivo studies in animal models are critical tools necessary to study the fundamental complexity of carcinogenesis. A constant strive to improve animal models in cancer exists, especially those investigating the use of chemotherapeutic effectiveness. In the present systematic review, colorectal cancer (CRC) is used as an example to highlight and critically evaluate the range of reporting strategies used when investigating chemotherapeutic agents in the preclinical setting. A systematic review examining the methodology and reporting of preclinical chemotherapeutic drug studies using CRC murine models was conducted. A total of 45 studies were included in this systematic review. The literature was found to be highly heterogeneous with various cell lines, animal strains, animal ages and chemotherapeutic compounds/regimens tested, proving difficult to compare outcomes between similar studies or indeed gain any significant insight into which chemotherapeutic regimen caused adverse events. From this analysis we propose a minimum core outcome dataset that could be regarded as a standardised way of reporting results from in vivo experimentation.

Text
1-s2.0-S1040842816302979-main - Accepted Manuscript
Download (938kB)

More information

Accepted/In Press date: 13 February 2017
e-pub ahead of print date: 16 February 2017
Published date: April 2017
Organisations: Cancer Sciences

Identifiers

Local EPrints ID: 406348
URI: http://eprints.soton.ac.uk/id/eprint/406348
ISSN: 1040-8428
PURE UUID: 3e176fec-bdd4-40b6-be31-be1f525ebecd
ORCID for M.A. West: ORCID iD orcid.org/0000-0002-0345-5356
ORCID for E. Sayan: ORCID iD orcid.org/0000-0002-5291-1485
ORCID for J.N. Primrose: ORCID iD orcid.org/0000-0002-2069-7605
ORCID for T.J. Underwood: ORCID iD orcid.org/0000-0001-9455-2188

Catalogue record

Date deposited: 10 Mar 2017 10:45
Last modified: 16 Mar 2024 05:04

Export record

Altmetrics

Contributors

Author: M.A. West ORCID iD
Author: A. Roman
Author: E. Sayan ORCID iD
Author: J.N. Primrose ORCID iD
Author: S.R. Wedge
Author: T.J. Underwood ORCID iD
Author: A.H. Mirnezami

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×